Market Overview:
The global Gatifloxacin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of infectious diseases, increasing demand for synthetic antibacterial drugs and growing awareness about ophthalmic medicines. However, the high cost of treatment and lack of awareness in some regions are restraining the growth of this market. On the basis of type, the global Gatifloxacin market is segmented into tablet, aqueous solution, capsule and others. The tablet segment is expected to account for a major share in terms of revenue due to its high adoption rate across various applications. On the basis of application, synthetic antibacterial drugs are expected to account for a major share in terms of revenue due their widespread use against various bacterial infections.
Product Definition:
Gatifloxacin is a fourth-generation fluoroquinolone antibiotic. It is prescribed to treat bacterial infections, including pneumonia, bronchitis, sinus infections and urinary tract infections.
Tablet:
Tablet is a form of oral drug delivery that has gained significant market share in the pharmaceutical industry. It is a small container made up of glass or plastic, which contains an amount of drug substance usually for injectable drugs. The tablet consists of two parts, namely the core and shell. The core holds the drug while it's outside layer protects it from disintegration and offers taste masking properties when taken with water or any other beverage.
Aqueous Solution:
Aqueous solution is a colligative chemical, which means it's a substance that combines with other substances to form more complex compounds. In Gatifloxacin case, the solution contains of water and gatifloxacin hydrochloride. The combination allows the drug to be used in different formulations such as solutions, suspensions, emulsions & pastes. It also helps in increasing drug stability by eliminating its sensitivity towards light & temperature.
Application Insights:
Synthetic antibacterial was the largest application of gatifloxacin in 2017. It is used to treat bacterial infections caused by various species such as methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Klebsiella pneumoniae. Gatifloxacin is also indicated for the treatment of urinary tract infections due to its activity against strains such as E.coli and Proteus mirabilis when other drugs are ineffective or cannot be used.
The ophthalmic medicine segment held the second-largest share of gatifloxacin demand in 2017 owing to increasing product use for treating eye diseases caused by bacteria, fungi or parasites that have entered through the eyes into the body cavities or from another part of body into eyesight organs causing inflammation, pain and loss of vision among others symptoms like redness & itching around eyes area & Vision blurriness etc.
Regional Analysis:
North America dominated the global Gatifloxacin market in 2017. The presence of a large number of manufacturers coupled with high consumer awareness levels and relatively higher healthcare expenditure are some factors responsible for its largest share. In addition, increasing resistance against other antibiotics and growing concern about side effects associated with fluoroquinolones is expected to drive Gatifloxacin sales in this region.
Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period owing to rising disposable income levels, improving economic conditions, expanding patient pool along with increased medical tourism especially from emerging countries such as India & China & Malaysia etc., which will fuel growth during the forecast period. Moreover, increasing investment by leading pharmaceutical companies for R&D activities will also support growth over coming years (8). For instance; Sun Pharmaceutical Industries Ltd.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the Gatifloxacin market. This is because infections caused by bacteria are becoming more common and resistant to antibiotics, which has led to an increase in the demand for Gatifloxacin.
- Rising awareness about antibiotic resistance: There is a growing awareness among people about antibiotic resistance and its implications on human health, which is driving them to opt for antibiotics such as Gatifloxacin.
- Growing demand from emerging markets: The demand for Gatifloxacin is growing rapidly in emerging markets such as India and China due to the increasing prevalence of infectious diseases in these regions.
- rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are investing heavily in research and development (R&D) activities to develop new drugs, including antibiotics such as Gatifloxacin, thereby boosting the growth of the market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gatifloxacin Market Research Report
By Type
Tablet, Aqueous Solution, Capsule, Others
By Application
Synthetic Antibacterial, Ophthalmic Medicine, Other
By Companies
Pacific Pharma, Apotex, Sandoz, Allergan, Bristol-Myers Squibb, Mylan, Hi Tech Pharmacal, Lupin Pharmaceuticals, Teva Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Gatifloxacin Market Report Segments:
The global Gatifloxacin market is segmented on the basis of:
Types
Tablet, Aqueous Solution, Capsule, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Synthetic Antibacterial, Ophthalmic Medicine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pacific Pharma
- Apotex
- Sandoz
- Allergan
- Bristol-Myers Squibb
- Mylan
- Hi Tech Pharmacal
- Lupin Pharmaceuticals
- Teva Pharmaceuticals
Highlights of The Gatifloxacin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Aqueous Solution
- Capsule
- Others
- By Application:
- Synthetic Antibacterial
- Ophthalmic Medicine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gatifloxacin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gatifloxacin is an antibiotic that is used to treat a variety of infections, including pneumonia. It works by killing the bacteria responsible for the infection. Gatifloxacin may also be used to treat other conditions as determined by your doctor.
Some of the major players in the gatifloxacin market are Pacific Pharma, Apotex, Sandoz, Allergan, Bristol-Myers Squibb, Mylan, Hi Tech Pharmacal, Lupin Pharmaceuticals, Teva Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gatifloxacin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gatifloxacin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gatifloxacin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gatifloxacin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gatifloxacin Market Size & Forecast, 2018-2028
4.5.1 Gatifloxacin Market Size and Y-o-Y Growth
4.5.2 Gatifloxacin Market Absolute $ Opportunity
Chapter 5 Global Gatifloxacin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gatifloxacin Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Aqueous Solution
5.2.3 Capsule
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gatifloxacin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gatifloxacin Market Size Forecast by Applications
6.2.1 Synthetic Antibacterial
6.2.2 Ophthalmic Medicine
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gatifloxacin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gatifloxacin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gatifloxacin Analysis and Forecast
9.1 Introduction
9.2 North America Gatifloxacin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gatifloxacin Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Aqueous Solution
9.6.3 Capsule
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gatifloxacin Market Size Forecast by Applications
9.10.1 Synthetic Antibacterial
9.10.2 Ophthalmic Medicine
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gatifloxacin Analysis and Forecast
10.1 Introduction
10.2 Europe Gatifloxacin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gatifloxacin Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Aqueous Solution
10.6.3 Capsule
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gatifloxacin Market Size Forecast by Applications
10.10.1 Synthetic Antibacterial
10.10.2 Ophthalmic Medicine
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gatifloxacin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gatifloxacin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gatifloxacin Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Aqueous Solution
11.6.3 Capsule
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gatifloxacin Market Size Forecast by Applications
11.10.1 Synthetic Antibacterial
11.10.2 Ophthalmic Medicine
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gatifloxacin Analysis and Forecast
12.1 Introduction
12.2 Latin America Gatifloxacin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gatifloxacin Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Aqueous Solution
12.6.3 Capsule
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gatifloxacin Market Size Forecast by Applications
12.10.1 Synthetic Antibacterial
12.10.2 Ophthalmic Medicine
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gatifloxacin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gatifloxacin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gatifloxacin Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Aqueous Solution
13.6.3 Capsule
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gatifloxacin Market Size Forecast by Applications
13.10.1 Synthetic Antibacterial
13.10.2 Ophthalmic Medicine
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gatifloxacin Market: Competitive Dashboard
14.2 Global Gatifloxacin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pacific Pharma
14.3.2 Apotex
14.3.3 Sandoz
14.3.4 Allergan
14.3.5 Bristol-Myers Squibb
14.3.6 Mylan
14.3.7 Hi Tech Pharmacal
14.3.8 Lupin Pharmaceuticals
14.3.9 Teva Pharmaceuticals
